Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,223.5
18.9 (0.59%)

 

  • STI Straits Times Index
    3,223.5
    18.9 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.2
    1.0 (0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,652.4
    -385.9 (-1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,565.7
    -32.0 (-0.89%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,007.6
    -98.4 (-0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,605.4
    -51.5 (-0.77%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.6M
  • Value: 503.9M
  • Rise: 157
  • Fall: 101
  • Unch: 493

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Koh Eco0.070+0.013
Tritech0.027+0.004
Raffles Edu0.071+0.012
Vividthree0.073+0.028
GKE0.147+0.008
Zhongxin Fruit0.053+0.008
ThaiBev0.730+0.015
Progen0.054+0.003
Boldtek0.112+0.003
Sunrise Shares0.089+0.006

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,626.0 -412.3
HSCEI 9,094.5 -165.0
Jakarta 6,605.4 -51.5
Nikkei 225 29,036.5 -69.5
SSE Comp 3,562.9 -34.7
Shanghai A 3,734.0 -36.4
Shanghai B 276.2 -1.2
KOSPI 3,026.0 -23.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

JCT JACK CHIA INDUSTRY THAILAND
Updated on 26 Oct 2021 (End of trading day)
Last (THB): 79.000 Change: - High: 79.000 Remarks: -
Change (%): - Low: 79.000
Open 79.000 Yesterday's Close 79.0
Buy Price 78.000 Sell Price 79.000
Buy Volume ('00) 8 Sell Volume ('00) 14
Cumulative Volume ('00) 1 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (THB) a 4.98650 Trailing EPS (THB) e 4.51761 NAV (THB) b 86.9014
PE a 15.843 Trailing PE f 17.487 Price / NAV b 0.9091
Dividend (THB) d 3.500000 Cash In Hand (THB) g 10.5722 Issued & Paid-up Shares c 13,500,000
Dividend Yield (%) d 4.430 Price / Cash In Hand g 7.472 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 1,066.500
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 688.632
Piotroski F Score 5 Exchange Code JCT Par Value ( THB ) 10.00000
52 Weeks Volatility (%) 12.96 6-Month VWAP 78.629 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 19 Feb 2016.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 19 Feb 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference JCT SET 1,066.500 15.843 17.487 0.9091 4.430
Industry Pharmaceuticals: Major SET 2,576.449 85.106 80.886 6.1239 0.505
Local Peer IP SET 6,645.690 123.580 100.050 13.0379 0.073
Global Peer JOHNSON & JOHNSON NYSE 436,333.560 29.654 24.403 - 2.401
Global Peer PFIZER INC NYSE 244,227.416 25.398 18.463 3.4869 3.488
Global Peer ELI LILLY AND COMPANY NYSE 237,652.984 38.370 39.148 36.8775 1.191
Global Peer MERCK & CO INC NYSE 208,205.182 29.462 37.373 6.2535 3.014
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 206,536.193 25.587 22.989 3.8218 2.272
Global Peer ABBVIE INC NYSE 193,488.538 42.469 29.365 15.3940 4.415
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 192,898.290 60.356 51.153 12.3053 1.865
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 190,284.316 29.530 26.729 18.2002 1.253
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,415.686 - - 3.5160 3.190
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,245.922 8.993 18.230 1.6834 -
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), INNOVENT BIOLOGICS INC (HKEx), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), ORGANON & CO (NYSE), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), NEKTAR THERAPEUTICS (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), QUANTERIX CORPORATION (NASDAQ), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), SSY GROUP LIMITED (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), OCUMENSION THERAPEUTICS (HKEx), CSTONE PHARMACEUTICALS (HKEx), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), ZYMEWORKS INC (NYSE), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), ATEA PHARMACEUTICALS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), PRAXIS PRECISION MEDICINES INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), GOSSAMER BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ANTENGENE CORP LTD (HKEx), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), GH RESEARCH PLC (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), ALIGOS THERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANNEXON INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), VERU INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), BEYONDSPRING INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), HUA MEDICINE (HKEx), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), Soho Global Health Tbk. (IDX), BOLT BIOTHERAPEUTICS INC (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), CHINOOK THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), IGBB (Bursa), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), RACE ONCOLOGY LTD (ASX), 89BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), CLEARSIDE BIOMEDICAL INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NEXIMMUNE INC (NASDAQ), ATHENEX INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), XOMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), OYSTER POINT PHARMA INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), DURECT CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), PHARMA (Bursa), VINCERX PHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), ANNOVIS BIO INC (NYSE American), TRICIDA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), OBSEVA SA (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), MUSTANG BIO INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), HOOKIPA PHARMA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), IX Biopharma (SGX), AYALA PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), NEUBASE THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), LOGICBIO THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), VTV THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LANTERN PHARMA INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), Merck Tbk. (IDX), EDESA BIOTECH INC (NASDAQ), LANNETT CO INC (NYSE), GENPREX INC (NASDAQ), EYENOVIA INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), KOTRA (Bursa), DARE BIOSCIENCE INC (NASDAQ), MEDIWOUND LTD (NASDAQ), CRESO PHARMA LTD (ASX), IMARA INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), GALECTO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), Phapros Tbk. (IDX), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), NOVA (Bursa), PAK FAH YEOW INTERNATIONAL (HKEx), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), Hyphens Pharma (SGX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EXOPHARM LTD (ASX), SYNAPTOGENIX INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), BIOHLDG (Bursa), INVION LTD (ASX), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), BAUDAX BIO INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), PALLA PHARMA LTD (ASX), PURAPHARM CORPORATION LIMITED (HKEx), SEQLL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), PHARMAXIS (ASX), CNS PHARMACEUTICALS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), XORTX THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), ONCOSIL MEDICAL LIMITED (ASX), SUNZEN (Bursa), TREVI THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), PANBELA THERAPEUTICS INC (NASDAQ), ACRUX (ASX), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), TALI DIGITAL LIMITED (ASX), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), AROVELLA THERAPEUTICS LTD (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.750
-0.94 %
10 Days ---
20 Days ---
Medium Term Return 3 Months -+1.500
+1.94 %
6 Months --1.500
-1.86 %
1 Year 7.000+2.000
+11.69 %
Long Term Return 2 Years 11.200-5.750
+6.43 %
3 Years 15.400-8.250
+8.19 %
5 Years 23.500+4.500
+37.58 %
Annualised Return Annualised --
+6.59 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 73.750 - 90.000 Change From 1 Year Low +5.250 % Change From 1 Year Low (%) +7.12
Change From 1 Year High -11.000 % Change From 1 Year High (%) -12.22
2 Years Range 62.000 - 90.000 Change From 2 Years Low +17.000 % Change From 2 Years Low (%) +27.42
Change From 2 Years High -11.000 % Change From 2 Years High (%) -12.22
5 Years Range 62.000 - 112.000 Change From 5 Years Low +17.000 % Change From 5 Years Low (%) +27.42
Change From 5 Years High -33.000 % Change From 5 Years High (%) -29.46
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Jack Chia Industry (Thailand) Public Co. Ltd. engages in the manufacture and distribution of pharmaceuticals and toiletries. Its products include cosmetics under the brand Tabu and Five Peacock, candy under the brand Jason's Jubjub, medicine and medical supplies such as plaster Tensoplast and Tigerplast, medical devices under the brand name Omron and oil lighters under the brand Ronson. The company was founded on September 1, 1966 and is headquartered in Bangkok, Thailand.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Oct 2021 79.000 79.000 79.000 79.000 100 79.0000
25 Oct 2021 78.750 79.000 78.750 79.000 500 78.8500
21 Oct 2021 79.750 79.750 79.750 79.750 - -
20 Oct 2021 79.750 79.750 79.750 79.750 200 79.7500
19 Oct 2021 79.750 79.750 79.750 79.750 100 79.7500
18 Oct 2021 79.000 79.000 79.000 79.000 - -
15 Oct 2021 79.000 79.000 79.000 79.000 - -
14 Oct 2021 79.000 79.000 79.000 79.000 - -
12 Oct 2021 79.000 79.000 79.000 79.000 - -
11 Oct 2021 79.000 79.000 79.000 79.000 300 79.0000
08 Oct 2021 77.500 77.500 77.500 77.500 - -
07 Oct 2021 77.500 77.500 77.500 77.500 - -
06 Oct 2021 77.500 77.500 77.500 77.500 200 77.5000
05 Oct 2021 78.750 78.750 78.750 78.750 100 78.7500
04 Oct 2021 77.000 78.750 77.000 78.750 1,700 77.7059
01 Oct 2021 79.000 79.500 79.000 79.000 900 79.0556
30 Sep 2021 79.000 79.000 79.000 79.000 - -
29 Sep 2021 79.000 79.000 79.000 79.000 - -
28 Sep 2021 79.000 79.000 79.000 79.000 - -
27 Sep 2021 79.000 79.000 79.000 79.000 - -
23 Sep 2021 79.000 79.000 79.000 79.000 - -
22 Sep 2021 79.000 79.000 79.000 79.000 100 79.0000
Summary
Current 2 Weeks
(11 Oct 2021 to 26 Oct 2021)
79.000 79.750 78.750 79.000 1,200 -
Previous 2 Weeks
(27 Sep 2021 to 08 Oct 2021)
79.000 79.750 78.750 77.500 2,900 -
4 Weeks from
(27 Aug 2021 to 23 Sep 2021)
76.500 79.750 76.500 79.000 2,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.